Title : p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.

Pub. Date : 2014 Nov 15

PMID : 25071015






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab. Glucose tumor protein p53 Homo sapiens
2 In the early setting, data suggested longer disease free survival in p53 negative patients in the lowest glucose category (p=0.053). Glucose tumor protein p53 Homo sapiens